Northwest ATTC Webinar: Transcranial Magnetic Stimulation in the Treatment of Stimulant Use Disorder (June 25, 2025, 11am PT)
05/29/2025
Join the Northwest ATTC (housed at ADAI), the Pacific Southwest ATTC, and the Western States Node of the NIDA Clinical Trials Network this June for their next joint webinar:
CTN-0108: Transcranial Magnetic Stimulation in the Treatment of Stimulant Use Disorder
Presenter: Kathleen T. Brady, MD, PhD
June 25, 2025 | 11am-12:30pm PT
In this session, Kathleen T. Brady, MD, PhD, of the Medical University of South Carolina, will discuss the NIDA Clinical Trials Network (CTN) study CTN-0108, “Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder,” a pilot study that aims to determine the feasibility, effectiveness, and safety for 20 sessions of repetitive transcranial magnetic stimulation (rTMS) versus sham in adults with a diagnosed methamphetamine or cocaine use disorder.
Dr. Brady, co-Principal Investigator for CTN-0108, will present the rationale for the study, including the literature supporting the use of rTMS in stimulant use disorder, as well as the study methodology and preliminary results.
1.5 CE/CME credits available! Select the type you’re interested in when you register and find complete accreditation information here.
